Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine kinase- specific for the mammalian RNA polymerase II: Possible role in transcription elongation

Cell Growth and Differentiation

Volumn 10, Issue 6, 1999, Pages 387-396

  Baskaran, Rajasekaran ^a,c   Escobar, Shawna R ^b,c   Wang, Jean Y J ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; PROTEIN TYROSINE KINASE; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SPECIES DIFFERENCE; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; CELL NUCLEUS; DROSOPHILA; GENE EXPRESSION REGULATION, VIRAL; GLUTATHIONE TRANSFERASE; HIV; HUMANS; MAMMALS; MICE; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-ABL; RECOMBINANT FUSION PROTEINS; RNA POLYMERASE II; SEQUENCE DELETION; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; TYROSINE; YEASTS;

EID: 0033022183     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Wang, J. Y. J. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev., 3: 35-43, 1993.
2. Wen, S-T., Jackson, P. K., and Van Etten, R. A. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J., 15: 1583-1595, 1996.
3. Taagepera, S., McDonald, D., Loeb, J. E., Whitaker, L. L. MacLeod, A. K., Wang, J. Y. J., and Hope, T. Nuclear-cytoplasmic shuttling of c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA, 95: 7457-7462, 1998.
4. Miao, Y., and Wang, J. Binding of A/T-rich DNA by three high mobility group like domains in c-Abl tyrosine kinase. J. Biol. Chem., 271: 22823-22830, 1996.
5. McWhirter, J. R., and Wang, J. Y. J. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J., 12: 1533-1546, 1993.
6. Van Etten, R. A., Jackson, P. K., Baltimore, D., Sanders, M. C., Matsudaira, P. T., and Janmey, P. A. The COOH terminus of the c-Abl tyrosine kinase contains distinct F-and G-actin binding domains with bundling activity. J. Cell Biol., 124: 325-340, 1994.
7. Baskaran, R., Chiang, G. G., and Wang, J. Y. J. Identification of a binding site in c-Abl tyrosine kinase for the C-terminal repeated domain of RNA polymersase II. Mol. Cell. Biol., 16: 3361-3369, 1995.
8. Baskaran, R., Chiang, G., Mysliwiec, T., Krul, G., and Wang, J. Tyrosine phosphorylation of RNA polymerase II carboxyl-terminal domain by Abl-related gene (Arg) encoded tyrosine kinase. J. Biol. Chem., 272: 18905-18909, 1997.
9. Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T., and Mulligan, R. C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell, 65: 1153-1163, 1991.
10. m1 mutation show poor viability and depletion of selected B and T cell populations. Cell, 65: 1165-1175, 1991.
11. Young, R. A. RNA polymerase II. Annu. Rev. Biochem., 60: 689-715, 1991.
12. Corden, J. L. Tails of RNA polymerase II. Trends Biochem. Sci., 15: 838-387, 1990.
13. Baskaran, R., Dahmus, M., and Wang, J. Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc. Natl. Acad. Sci. USA, 90: 11167-11171, 1993.
14. Duyster, J., Baskaran, R., and Wang, J. Y. J. Src homology 2 domain as a specificity determinant in the c-Abl mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. Proc. Natl. Acad. Sci. USA, 92: 1555-1559, 1995.
15. Liu, Z., Baskaran, R., Lea-Chou, E., Wood, L., Chen, Y., Karin, M., and Wang, J. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature (Lond.), 384: 273-276, 1996.
16. Baskaran, R., Wood, L., Whitaker, L., Canman, C., Morgan, S., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M., and Wang, J. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature (Lond.), 387: 516-519, 1997.
17. Dahmus, M. E. The role of multisite phosphorylation in the regulation of RNA polymerase II activity. Prog. Nucleic Acid Res. Mol. Biol., 48: 143-179, 1994.
18. Dahmus, M. E. Phosphorylation of the C-terminal domain of RNA polymerase II. Biochim. Biophys. Acta, 1261: 171-182, 1995.
19. Dahmus, M. E. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem., 271: 19009-19012, 1996.
20. Chambers, R., and Dahmus, M. Purification and characterization of a phosphatase from HeLa cells which dephosphorylates the C-terminal domain of RNA polymerase II. J. Biol. Chem., 269: 26243-26248, 1994.
21. Chambers, R., Wang, B., Burton, Z., and Dahmus, M. The activity of COOH-termmal domain phosphatase is regulated by docking site in RNA polymerase II and by the general transcription factors IIF and IIB. J. Biol. Chem., 270: 14962-14969, 1995.
22. Akoulitchev, S., Makela, T., Weinberg, R., and Reinberg, D. Requirement for TFIIH kinase activity in transcription by RNA polymerase II. Nature (Lond.), 377: 557-560, 1995.
23. Jones, K. A. Taking a new TAK on Tat transactivation. Genes Dev., 11: 2593-2599, 1997.
24. Jones, K., and Peterlin, B. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem., 63: 717-743, 1994.
25. Chun, R., and Jeang, K. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-I. J. Biol. Chem., 271: 27888-27894, 1996.
26. Okamoto, H., Sheline, C., Corden, J., Jones, K., and Peterlin, B. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. USA, 93: 11575-11579, 1996.
27. Parada, C., and Roeder, R. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature (Lond.), 384: 375-378, 1996.
28. Yang, X., Herrmann, C., and Rice, A. The human immunodeficiency virus Tat proteins specifically associate with Tak in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol., 70: 4576-4584, 1996.
29. Garcia-Matinez, L. F., Mavankal, G., Neveu, J. M., Lane, W. S., Ivanov, D., and Gaynor, R. B. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J., 16: 2836-2850, 1997.
30. Mancebo, H., Lee, G., Flygare, J., Tomassini, J., Luu, P., Zhu, Y., Peng, J., Blau, C., Hazula, D., Price, D., and Flores, O. P-TEF kinase is required for HIV Tat transcriptional activation In vivo and in vitro. Genes Dev., 11: 2633-2644, 1997.
31. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M., and Price, D. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev., 11: 2622-2632, 1997.
32. Welch, P. J., and Wang, Y. J. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell, 75: 779-790, 1993.
33. Welch, P., and Wang, J. Y. J. Disruption of ratinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev., 9: 31-46, 1995.
34. Doppler, C., Schalasta, G., Amtmann, E., and Sauer, G. Binding of NF-κB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity. AIDS Res. Hum. Retroviruses, 8: 245-252, 1992.
35. Songyang, Z., Blechner, S., Hoagland, N., Hoekstra, M. F., Pniwica-Worms, H., and Cantley, L. C. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr. Biol., 4: 973-982, 1994.
36. Lee, J. M., and Greenleaf, A. L. Modulation of RNA polymerase II elongation efficiency by C-terminal heptapeptide repeat domain kinase I. J. Biol. Chem., 272: 10990-10993, 1997.
37. Dikstein, R., Agami, R., Heffetz, D., and Shaul, Y. p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues. Proc. Natl. Acad. Sci. USA, 93: 2387-2391, 1996.
38. Welch, P. J., and Wang, J. Y. J. Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol. Cell. Biol., 15: 5542-5551, 1995.
39. Peterson, S., Kurimasa, A., Oshimura, M., Dynan, W., Bradbury, E., and Chen, D. Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. Proc. Natl. Acad. Sci. USA, 92: 3171-3174, 1995.
40. Lin, B. T. Y., Gruenwald, S., Lee, W-H., and Wang, J. Y. J. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J., 10: 857-863, 1991.
41. Gorman, C. M., Moffat, L. F., and Howard, B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol., 2: 1044-1051, 1982.